A comprehensive view of vaccination / immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Australia: BioNTech SE Receives Patent for 'Dose determination for immunotherapeutic agents'

HI HB2553: Relating To Pharmacists.

Biopharma firm CureVac NV and the University of Texas MD Anderson Cancer Center partner to develop novel mRNA-based cancer vaccines; the collaboration will focus on creating vaccines for hematological and solid tumor indications

AstraZeneca to present new data on its vaccine & immune therapies portfolio at the 34th European Congress of Clinical Microbiology & Infectious Diseases; the company will showcase 19 abstracts

Novavax's updated non-mRNA COVID-19 vaccine, Nuvaxovid XBB.1.5, now available in UK for 2024 vaccination season following receipt of wholesale license and green book update

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count